Èñòîðèÿ èíñòèòóòà
Íàöèîíàëüíûé èíñòèòóò ôòèçèàòðèè è
ïóëüìîíîëîãèè èì Ô.Ã. ßíîâñêîãî

Ïîñåòèòå íàøó ñòðàíèöóâ Facebook

 

Êëèíèêà
Êîíòàêòû

Ïåðåõîä íà òèòóëüíóþ ñòðàíèöóÏîèñê ïî ñàéòó

Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë

Îá èíñòèòóòå:

èñòîðèÿ,

îáùèå ïîëîæåíèÿ,

ñòðóêòóðà,

íàó÷íàÿ äåÿòåëüíîñòü,

ïëàíû ÍÈÐ,

ëå÷åáíî-äèàãíîñòè÷åñêàÿ ðàáîòà,

âåäóùèå ó÷åíûå

Íîâîñòè:

íîâèíêè íà ñàéòå

Íàøè èçäàíèÿ:

"Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë" (ÓÏÆ),
"Óêðàèíñêèé õèìèîòåðàïåâòè÷åñêèé æóðíàë" (ÓÕÆ),
"Àñòìà è àëëåðãèÿ"

Îðèãèíàëüíûå ñòàòüè:

îðèãèíàëüíûå íàó÷íûå ñòàòüè, ðàíåå íèãäå íå ïóáëèêîâàâøèåñÿ

Íîâîââåäåíèÿ:

ìåòîäè÷åñêèå ðåêîìåíäàöèè, èíôîðìàöèîííûå ïèñüìà,
âåäîìñòâåííûå èíñòðóêöèè,
íîâîââåäåíèÿ, ìîíîãðàôèè

Ïàòåíòû:

ïàòåíòû è àâòîðñêèå ñâèäåòåëüñòâà èíñòèòóòà

Îò÷åòû î ÍÈÐ:

ðåôåðàòû çàêîí÷åííûõ íàó÷íî-èññëåäîâàòåëüñêèõ ðàáîò

Ïîäãîòîâêà êàäðîâ:

àñïèðàíòóðà,

êëèíè÷åñêàÿ îðäèíàòóðà,
êóðñû èíôîðìàöèè è ñòàæèðîâêè,

â ïîìîùü àñïèðàíòó è ñîèñêàòåëþ

Íàó÷íûå ôîðóìû:

ðåçîëþöèè è îáðàùåíèÿ ñúåçäîâ, êîíôåðåíöèé, ñîâåùàíèé...

Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâ:

îáçîðû ëèòåðàòóðû, ñòàòèñòè÷åñêàÿ èíôîðìàöèÿ, íîâîå â ëå÷åíèè òóáåðêóëåçà è íåñïåöèôè÷åñêèõ çàáîëåâàíèé ëåãêèõ...

Èíôîðìàöèÿ äëÿ íàñåëåíèÿ:

ïîëåçíàÿ èíôîðìàöèÿ î çàáîëåâàíèÿõ ëåãêèõ, èõ ïðîôèëàêòèêå è ëå÷åíèè

2017. - ¹ 2.
Ç̲ÑÒ / ÑÎÄÅÐÆÀÍÈÅ / CONTENTS

ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÔÒÈDzÀÒв¯ / ACTUAL ISSUES OF PHTHISIOLOGY
 

Þ. ². Ôåùåíêî, Í. À. Ëèòâèíåíêî, Ì. Â. Ïîãðåáíà, Þ. Î. Ñåíüêî, Ë. Ì. Ïðîöèê
ÀÌÁÓËÀÒÎÐÍŠ˲ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÒÓÁÅÐÊÓËÜÎÇ: «ÇÀ» ÒÀ «ÏÐÎÒÈ»

®

Yu. I. Feshchenko, N. A. Lytvynenko, M. V. Pogrebna, Y. O. Senko, L. M. Protsyk
AMBULATORY TREATMENT FOR TUBERCULOSIS PATIENTS: PRO ET CONTRA

 

V. P. Melnyk, T. G. Khursa, Y. O. Yakymova
PREVALENCE OF TB/HIV CO-INFECTION AMONG THE RESIDENTS OF THE LEFT BANK PART OF KYIV CITY

®

V. P. Melnyk, T. G. Khursa, Y. O. Yakymova
PREVALENCE OF TB/HIV CO-INFECTION AMONG THE RESIDENTS OF THE LEFT BANK PART OF KYIV CITY

 

 

ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ORIGINALS

 

Å. À. Ìåðåíêîâà
ÐÅÇÓËÜÒÀÒÛ ÌÎÍÎÒÅÐÀÏÈÈ ÀÇÀÒÈÎÏÐÈÍÎÌ ÁÎËÜÍÛÕ ÑÀÐÊÎÈÄÎÇÎÌ ËÅÃÊÈÕ Ñ ÏÐÎÒÈÂÎÏÎÊÀÇÀÍÈßÌÈ Ê ÍÀÇÍÀ×ÅÍÈÞ ÈËÈ ÑÅÐÜÅÇÍÛÌÈ ÏÎÁÎ×ÍÛÌÈ ÄÅÉÑÒÂÈßÌÈ ÃËÞÊÎÊÎÐÒÈÊÎÑÒÅÐÎÈÄÎÂ

®

E. A. Merenkova
OUTCOMES OF AZATHIOPRINE MONOTHERAPY IN PULMONARY SARCOIDOSIS PATIENTS WITH CONTRAINDICATIONS FOR USE OR SERIOUS ADVERSE REACTIONS TO GLUCOCORTICOSTEROIDS
 

Î. Ì. Ðåêàëîâà, Ë. Â. Ïåòðåíêî
ÔÓÍÃÀËÜÍÀ ÀËÅÐÃ²ß Ó ÕÂÎÐÈÕ ÍÀ ËÅÃÊÓ ÒÀ ÑÅÐÅÄÍÜί ÒßÆÊÎÑÒ² ÁÐÎÍÕ²ÀËÜÍÓ ÀÑÒÌÓ: Ê˲Ͳ×Ͳ, ÔÓÍÊÖ²ÎÍÀËÜͲ, ÀËÅÐÃÎËÎò×Ͳ, ËÀÁÎÐÀÒÎÐͲ ÎÑÎÁËÈÂÎÑÒ²

®

E. M. Rekalova, L. V. Petrenko
FUNGAL ALLERGY IN PATIENTS WITH MILD AND MODERATE ASTHMA: CLINICAL, FUNCTIONAL, ALLERGIC, LABORATORY FEATURES

 

Ê. Â. Íàçàðåíêî
ÄÈÍÀ̲ÊÀ ÔÓÍÊÖ²¯ ÇÎÂͲØÍÜÎÃÎ ÄÈÕÀÍÍß ÏÐÈ ÊÎÌÏËÅÊÑÍÎÌÓ Ë²ÊÓÂÀÍͲ ÕÂÎÐÈÕ ÍÀ ÑÏÎËÓ×ÅÍÓ ÏÀÒÎËÎÃ²Þ ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ ÒÀ ÕÎÇË ÇÀ ÄÀÍÈÌÈ ²ÌÏÓËÜÑÍί ÎÑÖÈËÎÌÅÒв¯

®

K. V. Nazarenko
PULMONARY FUNCTION, ASSESSED BY IMPULSE OSCILLOMETRY, IN ACOS PATIENTS ON COMPLEX TREATMENT

 

Î. ². Ëåìêî, Ñ. Â. Ëóêàùóê, Í. Â. Âàíòþõ
ÃÀËÎÀÅÐÎÇÎËÜÒÅÐÀÏ²ß Ó Â²ÄÍÎÂËÞÂÀËÜÍÎÌÓ Ë²ÊÓÂÀÍͲ IJÒÅÉ Ç ÐÅÖÈÄÈÂÓÞ×ÈÌ ÁÐÎÍÕ²ÒÎÌ

®

O. I. Lemko, S. V. Lukashchuk, N. V. Vantyukh
HALOAEROSOL THERAPY IN REHABILITATIVE TREATMENT OF CHILDREN WITH RECURRENT BRONCHITIS

 

Ë. Â. Ñàâ÷åíêî, ². Ï. Êàéäàøåâ
À˲ÌÅÍÒÀÐÍÅ ÎÆÈвÍÍß ÂÍÀÑ˲ÄÎÊ ÏÎÐÓØÅÍÍß ÕÀÐ×ÎÂί ÏÎÂÅIJÍÊÈ ÏÎòÐØÓª Ê˲Ͳ×ÍÈÉ ÏÅÐÅÁ²Ã ÕÐÎͲ×ÍÎÃÎ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ

®

L. V. Savchenko, I. P. Kaidashev
ALIMENTARY OBESITY DUE TO DISORDERS OF EATING BEHAVIOR WORSENS THE CLINICAL COURSE OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 

 

ÏÐÀÊÒÈ×Ͳ ÐÅÊÎÌÅÍÄÀÖ²¯ / PRACTICAL RECOMMENDATIONS

 

Í. Ñ. Ìîðîçîâà, Â. Ô. Ìàðèåâñêèé, Ñ. Â. Ðèäíûé, È. Â. Êîðîáêîâà, À. À. Ïîïîâ, À. Å. Êàðïåíêî, À. Â. Âûøíÿêîâà
ÄÅÇÈÍÔÅÊÒÎËÎÃÈ×ÅÑÊÀß ÏÐÎÔÈËÀÊÒÈÊÀ ÒÓÁÅÐÊÓ˨ÇÀ

®

N. S. Morozova, V. F. Marievsky, S. V. Readney, I. V. Korobkova, A. A. Popov, A. E. Karpenko, G. V. Vishnyakova
DISINFECTOLOGICAL PREVENTION OF TUBERCULOSIS

 

ÌÀÒÅвÀËÈ ÍÀÓÊÎÂÎ-ÏÐÀÊÒÈ×Íί ÊÎÍÔÅÐÅÍÖ²¯ “ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÂÅÄÅÍÍß ÕÂÎÐÈÕ ÍÀ ղ̲ÎÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ÍÀ ÑÒÀÖ²ÎÍÀÐÍÎÌÓ ÒÀ ÀÌÁÓËÀÒÎÐÍÎÌÓ ÅÒÀÏÀÕ” 30 ÁÅÐÅÇÍß 2017 ÐÎÊÓ / PROCEEDINGS OF SCIENTIFIC CONFERENCE “MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS PATIENTS AT HOSPITAL AND IN OUT-PATIENT SETTINGS”, MARCH 30, 2017

 

À. ². Áàðáîâà, Í. Ì. À볺âà
ÇÀÑÒÎÑÓÂÀÍÍß ÑÈÑÒÅÌÈ ÂÀÑÒÅÑ MGIT 960 ÄËß ÄÎÑ˲ÄÆÅÍÜ Ê˲Ͳ×ÍÎÃÎ ÌÀÒÅвÀËÓ ÕÂÎÐÈÕ ÍÀ ÒÓÁÅÐÊÓËÜÎÇ ËÅÃÅÍÜ

®

À. ². Barbova, N. Ì. Àlieva
APPLICATION OF THE ÂÀÑÒÅÑ MGIT 960 SYSTEM FOR EXAMINATION OF SAMPLES FROM PULMONARY TUBERCULOSIS PATIENTS
 

Î. ². Á³ëîãîðöåâà, À. ². Áàðáîâà, ². ª. Øåõòåð, Î. Ï. Íåäîñïàñîâà, À. Ñ. Ô³ðñîâà
ÑÒÐÓÊÒÓÐÀ Ê˲Ͳ×ÍÈÕ ÔÎÐÌ ÒÀ ÎÑÎÁËÈÂÎÑÒ² ÁÀÊÒÅвÎÂÈIJËÅÍÍß Ó Ä²ÒÅÉ Ç ÂÏÅÐØŠIJÀÃÍÎÑÒÎÂÀÍÈÌ ÒÓÁÅÐÊÓËÜÎÇÎÌ

®

Î. ². Bilogortseva, À. ². Barbova, ². Ye. Shekher, Î. P. Nedospasova, À. S. Firsova
STRUCTURE OF CLINICAL FORMS AND PECULIARITIES OF BACTERIOSIS IN CHILDREN WITH THE FIRST DIAGNOSIS OF TUBERCULOSIS
 

Ã. Î. Âàðèöüêà, Í. À. Ëèòâèíåíêî, Î. Ð. Ïåíåíêî, Ò. Ì. Ìàðöèíþê
ÄÎÑÂ²Ä ÇÀÑÒÎÑÓÂÀÍÍß ÑÊÎÐÎ×ÅÍÎÃÎ 12-̲Ñß×ÍÎÃÎ ÐÅÆÈÌÓ Õ²Ì²ÎÒÅÐÀϲ¯ ÄËß ÕÂÎÐÈÕ ÍÀ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÛÉ ÒÓÁÅÐÊÓËÜÎÇ Â ÓÊÐÀ¯Í²

®

G. Î. Varytska, N. À. Lytvynenko, Î. R. Penenko, Ò. Ì. Martsyniuk
EXPERIENCE OF THE APPLICATION OF THE DERIVED 12-MONTH CHEMOTHERAPY IN PATIENTS WITH MDR-TUBERCULOSIS IN UKRAINE
 

Ë. Ì. Çàãàáà, ². Â. ˳ñê³íà, Ñ. Ä. Êóçîâêîâà, Î. Î. Ìåëüíèê
ÂÈÇÍÀ×ÅÍÍß Ð²ÂÍß ÅÊÑÏÐÅѲ¯ ̲ÊÎÁÀÊÒÅвÀËÜÍÈÕ ÀÍÒÈÃÅÍ²Â Ó ÌÀÊÐÎÔÀÃÀÕ ËÅÃÅÍÅÂί ÒÊÀÍÈÍÈ ÏÐÈ ÒÓÁÅÐÊÓËÜÎÌÀÕ

®

L. Ì. Zagaba, ². V. Liskina, S. D. Kuzovkova, Î. Î. Melnyk
DETERMINATION OF THE LEVEL OF EXPRESSION OF MYCOBACTERIAL ANTIGENS IN MACROPHAGES OF THE PULMONARY TISSUE IN TUBERCULOMAS
 

 

Ñ. Â. Çàéêîâ, Î. Ï. Ëèòâèíþê, Í. À. Ãð³öîâà, Î. Ä. ͳêîëàºâà, Â. Á. ßðîöèíñüêèé, Ë. Â. Âåñåëîâñüêèé
ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ Ó ÌÅÄÈ×ÍÈÕ ÏÐÀÖ²ÂÍÈʲÂ

®

S. V. Zajkov, Î. P. Lytvyniuk, N. À. Gritsova, Î. D. Nikolaeva, V. B. Yarotsynsky, L. V. Veselovsky
MDR-TUBERCULOSIS IN MEDICAL WORKERS
 

Â. ². ²ãíàòüºâà, Ñ. Â. Çàéêîâ, Î. Ä. ͳêîëàºâà, Â. À. Ñâÿòíåíêî
ÌÎÆËÈÂÎÑÒ² ÊÎÌÏ`ÞÒÅÐÍί ÒÎÌÎÃÐÀÔ²¯ ÑÊÐÎÍÅÂÈÕ Ê²ÑÒÎÊ Â Ä²ÀÃÍÎÑÒÈÖ² ÒÓÁÅÐÊÓËÜÎÇÍÎÃÎ ÑÅÐÅÄÍÜÎÃÎ ÎÒÈÒÓ ÒÀ ÎÖ²ÍÖ² ÅÔÅÊÒÈÂÍÎÑÒ² ˲ÊÓÂÀÍÍß

®

V. ². ²gnatieva, S. V. Zajkov, Î. D. Nikolaeva, V. À. Sviatnenko
COMPUTED TOMOGRAPHY OF TEMPORAL BONE IN THE DIAGNOSIS OF TUBERCULOSIS OTITIS MEDIA AND ESTIMATION OF THE EFFICIENCY OF TREATMENT
 

Ì. Ì. Êóæêî, Î. Þ. Ãðèá, Î. Ì. Ñòàðêîâà, À. Â. Òàðàíåíêî
ÐÅÇÈÑÒÅÍÒͲÑÒÜ ßÊ ÍÀÑ˲ÄÎÊ ÂÈÍÈÊÍÅÍÍß ÐÅÖÈÄȲ ÒÓÁÅÐÊÓËÜÎÇÓ ËÅÃÅÍÜ

®

Ì. Ì. Kuzhko, Î. Yu. Gryb, Î. Ì. Starkova, À. V. Òaranenko
RESISTANCE AS A RESULT OF THE PULMONARY TUBERCULOSIS RELAPSE
 

Ñ. Ä. Êóçîâêîâà, Ë. Ì. Çàãàáà, Î. Î. Ìåëüíèê, ². Â. ˳ñê³íà
ÂÈÇÍÀ×ÅÍÍß Ð²ÂÍß ÅÊÑÏÐÅѲ¯ ̲ÊÎÁÀÊÒÅвÀËÜÍÈÕ ÀÍÒÈÃÅͲ  Ê˲ÒÈÍÀÕ ÃÐÀÍÓËÜÎÌ ÏÐÈ ÒÓÁÅÐÊÓËÜÎÌÀÕ ËÅÃÅÍÜ

®

S. D. Êuzovkova, L. Ì. Zagaba, Î. Î. Ìålnyk, ². V. Liskina
DETERMINATION OF THE LEVEL OF EXPRESSION OF MYCOBACTERIAL ANTIGENS IN GRANULOMA CELLS FROM LUNG TUBERCULOMA
 

Í. À. Ëèòâèíåíêî, Í. Â. Ãðàíê³íà, Ì. Â. Ïîãðåáíà, Þ. Î. Ñåíüêî
ÅÔÅÊÒÈÂͲÑÒÜ ÇÀÑÒÎÑÓÂÀÍÍß ÌÅÐÎÏÅÍÅÌÓ ÏÐÈ Ë²ÊÓÂÀÍͲ ÕÂÎÐÈÕ ÍÀ ÒÓÁÅÐÊÓËÜÎÇ ²Ç ÐÎÇØÈÐÅÍÎÞ ÐÅÇÈÑÒÅÍÒͲÑÒÞ

®

N. À. Lytvynenko, N. V. Grankina, Ì. V. Pogrebna, Yu. Î. Senko
EFFICIENCY OF MEROPENEM IN TUBERCULOSIS PATIENTS WITH EXTENDED RESISTANCE
 

Â. Ì. Ìåëüíèê, Â. Ã. Ìàòóñåâè÷, ². Î. Íîâîæèëîâà, ². Â. Áóøóðà
ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÙÎÄΠղ̲ÎÐÅÇÈÑÒÅÍÒÍÎÃÎ ÒÓÁÅÐÊÓËÜÎÇÓ Â ÓÊÐÀ¯Í²

®

V. Ì. Ìålnyk, V. G. Ìàtusevych, ². Î. Novozhylova, ². V. Bushura
TOPICAL ISSUES OF CHEMO-RESISTANT TUBERCULOSIS IN UKRAINE
 

Î. Ä. ͳêîëàºâà
ÏÎÁ²×Ͳ ÐÅÀÊÖ²¯ ÏÐÈ Ë²ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ Â ÏΪÄÀÍͲ ²Ç ²Ë-²ÍÔÅÊÖ²ªÞ

®

Î. D. Nikolaeva
ADVERSE DRUG REACTIONS IN PATIENTS WITH MDR-TUBERCULOSIS AND HIV-INFECTION
 

Ì. Ñ. Îïàíàñåíêî, Ñ. Ì. Øàëàãàé, Î. Å. Êøàíîâñüêèé, Á. Ì. Êîí³ê, Î. Â. Òåðåøêîâè÷, Ì. ². Êàëåí³÷åíêî, Ë. ². Ëåâàíäà
²ÄÅÎÀÑÈÑÒÎÂÀͲ ÎÏÅÐÀÖ²¯ ÏÐÈ ÒÓÁÅÐÊÓËÜÎDz ËÅÃÅÍÜ

®

Ì. S. Îpanasenko, S. Ì. Shalagaj, Î. Å. Êshanovsky, B. Ì. Êînik, Î. V. Òåreshkovych, Ì. ². Êàlenichenko, L. ². Levanda
VIDEO-ASSISTED OPERATIONS IN LUNG TUBERCULOSIS
 

 

Ë. Ä. Òîäîð³êî, ². Î. Ñåì’ÿí³â
ÂÏËÈ ÀËÅËÜÍÎÃÎ ÏÎ˲ÌÎÐÔ²ÇÌÓ ÃÅͲ GSTT1 ÒÀ GSTM1 ÍÀ ÅÔÅÊÒÈÂͲÑÒÜ Ë²ÊÓÂÀÍÍß Õ²Ì²ÎÐÅÇÈÑÒÅÍÒÍÎÃÎ ÒÓÁÅÐÊÓËÜÎÇÓ

®

L. D. Òîdoriko, ². Î. Semianiv
INFLUENCE OF GENE POLYMORPHISM OF GSTT1 AND GSTM1 GENES ON THE EFFICIENCY OF CHEMORESISTANT TUBERCULOSIS TREATMENT
 

L. Todoriko, G. Popescu, M. Dumitru, I. Semianiv, E. Lesnic, I. ²åremenchuk
HIGH-RISK GROUPS FOR DRUG-RESISTANT TUBERCULOSIS FROM CHISINAU CITY, IASI COUNTY AND CHERNIVTSI REGION

®

L. Todoriko, G. Popescu, M. Dumitru, I. Semianiv, E. Lesnic, I. ²åremenchuk
HIGH-RISK GROUPS FOR DRUG-RESISTANT TUBERCULOSIS FROM CHISINAU CITY, IASI COUNTY AND CHERNIVTSI REGION
 

Î. Ï. ×îáîòàð, Í. À. Ëèòâèíåíêî, Â. Â. Äàâèäåíêî, Ë. Â. Ùåðáàêîâà
ÄÎÑÂ²Ä ÇÀÑÒÎÑÓÂÀÍÍß ÑÊÎÐÎ×ÅÍÎÃÎ 12-̲Ñß×ÍÎÃÎ ÐÅÆÈÌÓ Õ²Ì²ÎÒÅÐÀϲ¯ ÄËß ÕÂÎÐÈÕ ÍÀ ÌÐÒÁ Ç ÐÅÇÈÑÒÅÍÒͲÑÒÞ ÄÎ ÔÒÎÐÕ²ÍÎËÎͲ ÀÁÎ À̲ÍÎÃ˲ÊÎÇÈIJÂ/ÏÎ˲ÏÅÏÒÈIJ  ÓÊÐÀ¯Í²

®

Î. P. Chobotar, N. À. Lytvynenko, V. V. Davydenko, L. V. Shcherbakova
EXPERIENCE OF APPLICATION OF A 12-MONTH CHEMOTHERAPY IN PATIENTS WITH MDR-TB WITH RESISTANCE TO FLUOROQUINOLONES OR AMINOGLYCOSIDES / POLYPEPTIDES IN UKRAINE
 

ÌÀÒÅвÀËÈ VI ÍÀÓÊÎÂÎ-ÏÐÀÊÒÈ×Íί ÊÎÍÔÅÐÅÍÖ²¯ “ÀÊÒÓÀËÜͲ ÏÐÎÁËÅÌÈ Ë²ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ” 13 ʲÒÍß 2017 ÐÎÊÓ / PROCEEDINGS OF 6TH SCIENTIFIC CONFERENCE “ACTUAL PROBLEMS OF MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE”, APRIL 13, 2017

 

Þ. Ì. Ìîñòîâîé, À. Â. Äåì÷óê, Ò. Â. Êîíñòàíòèíîâè÷, À. À. Ñèäîðîâ, Ä. Â. ijäåíêî
ÏÐÎ ÇÀÏÀËÅÍÍß Â «ÊÂÀÄÐÀÒÀÕ» ÕÎÇË

®

Yu. Ì. Ìostovoj, À. V. Demchuk, Ò. V. Êînstantynovych, À. À. Sydorov, D. V. Didenko
INFLAMMATION THROUGH COPD QUADRANTS
 

Ò. À. Ïåðöåâà
ÎÑÎÁÅÍÍÎÑÒÈ ËÅ×ÅÍÈß ÏÀÖÈÅÍÒÎÂ Ñ ÁÐÎÍÕÎÎÁÑÒÐÓÊÒÈÂÍÛÌÈ ÇÀÁÎËÅÂÀÍÈßÌÈ Â ÑÎ×ÅÒÀÍÈÈ Ñ ÑÀÕÀÐÍÛÌ ÄÈÀÁÅÒÎÌ È ÎÆÈÐÅÍÈÅÌ

®

Ò. À. Pertseva
PECULIARITIES OF TREATMENT OF PATIENTS WITH BRONCHOOBSTRUCTIVE DISEASES IN CONJUNCTION WITH DIABETES AND OBESITY
 

Ì. Ì. Îñòðîâñüêèé
ßÊ ² ÍÀ²ÙÎ ×ÈÒÀÒÈ ²ÍÑÒÐÓÊÖ²Þ. ÊÅвÂÍÈÖÒÂÎ ÊÎÐÈÑÒÓÂÀ×À

®

Ì. Ì. Îstrovsky
HOW AND WHY TO READ INSTRUCTIONS FOR USE
 

Ò. À. Ïåðöåâà
ÍÎÂÛÅ ÂÎÇÌÎÆÍÎÑÒÈ ÂÛÁÎÐÀ ÄÎÑÒÀÂÎ×ÍÛÕ ÓÑÒÐÎÉÑÒ  ËÅ×ÅÍÈÈ ÁÐÎÍÕÈÀËÜÍÎÉ ÀÑÒÌÛ È ÕÐÎÍÈ×ÅÑÊÎÃÎ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÇÀÁÎËÅÂÀÍÈß ËÅÃÊÈÕ

®

Ò. À. Pertseva
NEW POSSIBILITIES OF SELECTION OF DELIVERY DEVICES IN TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 

Ì. Ì. Îñòðîâñüêèé
ÐÎËÜ Ò²ÎÒÐÎÏ²Þ ÁÐÎ̲ÄÓ Â Ë²ÊÓÂÀÍͲ ÕÎÇË Ç ÒÎ×ÊÈ ÇÎÐÓ ÎÍÎÂËÅÍÈÕ ÐÅÊÎÌÅÍÄÀÖ²É GOLD 2017 ÐÎÊÓ

®

Ì. Ì. Îstrovsky
THE ROLE OF TIOTROPIUM BROMIDE IN TREATMENT OF COPD IN LIGHT OF UPDATED GOLD-2017 RECOMMENDATIONS
 

Ì. Ì. Îñòðîâñüêèé
̲ÑÖÅ Ô²ÊÑÎÂÀÍί ÊÎÌÁ²ÍÀÖ²¯ ²ÍÄÀÊÀÒÅÐÎË/Ã˲ÊÎϲÐÐÎÍ²É Â ÍÎÂÈÕ ÐÅÊÎÌÅÍÄÀÖ²ßÕ GOLD-2017

®

Ì. Ì. Îstrovsky
PLACE OF FIXED COMBINATION INDACATEROL / GLICOPYRRONIUM IN NEW GOLD-2017 RECOMMENDATIONS
 

ß. À. Äçþáëèê
ÄÎÊÀÇÀÍÍÀß ÝÔÔÅÊÒÈÂÍÎÑÒÜ ÈÍÄÀÊÀÒÅÐÎËÀ/ ÃËÈÊÎÏÈÐÐÎÍÈß Â ÏÐÎÔÈËÀÊÒÈÊÅ ÎÁÎÑÒÐÅÍÈÉ ÕÎÇË: ÏÅÐÑÏÅÊÒÈÂÛ, ÎÒÊÐÛÒÛÅ ÈÑÑËÅÄÎÂÀÍÈÅÌ FLAME

®

Ya. À. Dziublik
PROVEN EFFECTIVENESS OF INDACATEROL / GLYCOPYRRONIUM IN PREVENTION OF COPD EXACERBATIONS: PERSPECTIVES DISCOVERED FLAME STUDY
 

Þ. Ì. Ìîñòîâîé, Ò. Â. Êîíñòàíòèíîâè÷, Í. Ñ. Ñëåï÷åíêî, Ã. Â. Ïîáåðåæåöü, Î. Â. Êàò³ëîâ, À. À. Ñèäîðîâ
ÏÎIJËÜÑÜÊÀ ÐÅÑϲÐÀÒÎÐÍÀ ØÊÎËÀ 2016 – ÎѲÒÍ²É ÏÐÎÅÊÒ ÄËß Ë²ÊÀв ѲÌÅÉÍί ÌÅÄÈÖÈÍÈ

®

Yu. Ì. Ìîstovoj, Ò. V. Êînstantynovych, N. S. Slepchenko, G. V. Poberezhets, Î. V. Êàtilov, À. À. Sydorov
PODILSKA RESPIRATORY SCHOOL 2016 – EDUCATIONAL PROJECT FOR GENERAL PRACTITIONERS
 

 

C. Â. Çàéêîâ
ÅÔÅÊÒÈÂͲÑÒÜ ÒÀ ÁÅÇÏÅÊÀ ²ÍÍÎÂÀÖ²ÉÍί ÔÎÐÌÈ ²ÍòÁ²ÒÎÐÀ ÔÎÑÔÎIJÅÑÒÅÐÀÇÈ ÏÐÈ ÇÀÃÎÑÒÐÅÍÍßÕ ÕÐÎͲ×ÍÎÃÎ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ ² ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ

®

S. V. Zajkov
EFFECTIVENESS AND SAFETY OF INNOVATIVE PHOSPHODIESTERASE INHIBITORS IN COPD AND ASTHMA
 

Ì. Ì. Îñòðîâñüêèé
ÌÎÆËÈÂÎÑÒ² ÇÀÑÒÎÑÓÂÀÍÍß β2 -ÀÃÎͲÑҲ ÒÐÈÂÀËί IJ¯  ˲ÊÓÂÀÍͲ ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ

®

Ì. Ì. Îstrovsky
USE OF LONG-ACTING β2-AGONISTS IN TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 

Å. Ñ. Ìàëèíîâñêàÿ
ÏÐÅÈÌÓÙÅÑÒÂÀ ÄÂÎÉÍÎÉ ÁÐÎÍÕÎÄÈËÀÒÀÖÈÈ Â ËÅ×ÅÍÈÈ ÕÎÇË

®

Å. S. Ìàlinovskaya
ADVANTAGES OF DUAL BRONDILATION IN TREATMENT OF COPD
 

Ñ. Ñ. Ñèìîíîâ
ÐÎËÜ ÑÎÂÐÅÌÅÍÍÛÕ ÌÀÊÐÎËÈÄΠ ËÅ×ÅÍÈÈ ÏÀÖÈÅÍÒÎÂ Ñ ÈÍÔÅÊÖÈÎÍÍÛÌ ÎÁÎÑÒÐÅÍÈÅÌ ÕÎÇË

®

S. S. Simonov
THE ROLE OF MODERN MACROLIDES IN TREATMENT OF PATIENTS WITH INFECTIOUS EXACERBATION OF COPD
 

ß. À. Äçþáëèê
ÏÅÐÑÏÅÊÒÈÂÛ ËÅ×ÅÍÈß ÁÎËÜÍÛÕ ÈÄÈÎÏÀÒÈ×ÅÑÊÈÌ ËÅÃÎ×ÍÛÌ ÔÈÁÐÎÇÎÌ

®

Ya. À. Dziublik
PROSPECTS FOR TREATMENT OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
 

²ÍÔÎÐÌÀÖ²ß / INFORMATION

 

Íβ ÂÈÌÎÃÈ ÄÎ ÎÔÎÐÌËÅÍÍß Á²Á˲ÎÃÐÀÔ²×ÍÎÃÎ ÎÏÈÑÓ Ë²ÒÅÐÀÒÓÐÍÈÕ ÄÆÅÐÅË
®

NEW REQUIREMENTS FOR THE DESIGNATION OF A BIBLIOGRAPHIC DESCRIPTION OF LITERARY SOURCES
 

ÀÂÒÎÐÀÌ ÆÓÐÍÀËÜÍÈÕ ÏÓÁ˲ÊÀÖ²É
®

INSTRUCTIONS TO THE AUTHORS
 

 

 



HomeÏîèñê Ïðî èíñòèòóòÍîâîñòè Íàøè èçäàíèÿ Îðèãèíàëüíûå ñòàòòüè Íîâîââåäåíèÿ
ÏàòåíòûÎò÷åòû î ÍÄÐ Ïîäãîòîâêà êàäðîâ Íàó÷íûå ôîðóìû
Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâÈíôîðìàöèÿ äëÿ íàñåëåíèÿÌåäèöèíñêèå óñëóãè


© Îòäåë ÈÊÒ
ÍÈÔÏ

Îòïðàâèòü E-mail â Èíñòèòóò

www.ifp.kiev.ua